最新试用
| EudraCT Number: 2004-001430-16 | Sponsor Protocol Number: 3066K1-305-WW | Start Date: 2005-04-20 | ||||||
| Sponsor Name: Wyeth Research, Division of Wyeth Pharmaceuticals, Inc. Clinical Research and Development | ||||||||
| Full Title: An Open-label, Randomized, Phase 3 Trial of intravenous Temsirolimus (CCI-779) at two Dose Levels Compared to Investigator's Choice Therapy in relapsed, Refractory Subjects with Mantle Cell lymphom... | ||||||||
| Medical condition: Mantle Cell Lymphoma | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: AT (Prematurely Ended) SE (Completed) GB (Completed) DE (Completed) IT (Completed) ES (Completed) | ||||||||
| Trial results: View results | ||||||||
| EudraCT Number: 2005-000048-10 | Sponsor Protocol Number: CCAD106A2101 | Start Date: 2005-04-20 | ||||||
| Sponsor Name: Novartis Pharma Services AG | ||||||||
| Full Title: A 52-week, multi-center, randomized, double-blind, placebo-controlled, time-lagged, parallel group study in patients with mild to moderate Alzheimer's Disease (AD) to investigate the safety, tolera... | ||||||||
| Medical condition: Alzheimer's disease | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: SE (Completed) | ||||||||
| Trial results: View results | ||||||||
| EudraCT Number: 2004-003944-23 | Sponsor Protocol Number: UFK-HEF 5 | Start Date: 2005-04-20 | ||||||
| Sponsor Name: Medical University of Vienna | ||||||||
| Full Title: Acetyl salicylic acid in the treatment of patients with positive margins after surgery for cervical dysplasia grade II-III: A phase II trial | ||||||||
| Medical condition: Cervical intraepithelial neoplasia grade II/III with positive margin after surgery | ||||||||
|
||||||||
| Population Age: Adults | Gender: Female | |||||||
| Trial protocol: AT (Prematurely Ended) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2004-002474-36 | Sponsor Protocol Number: IC51-301 | Start Date: 2005-04-20 | ||||||
| Sponsor Name: Intercell AG | ||||||||
| Full Title: Observer blinded, randomized Phase III study to investigate the non-inferiority of IC51 (JE-PIV) vs. JE-VAX as vaccines for japanese encephalitis in healthy volunteers | ||||||||
| Medical condition: Japanese encephalitis (JE) is the most common viral encephalitis, with over 50,000 cases reported annually. It is a considerable public health problem for many Asian countries (WHO 1997). Close to ... | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: AT (Completed) | ||||||||
| Trial results: View results | ||||||||
| EudraCT Number: 2004-001959-11 | Sponsor Protocol Number: CL3-16257-056 | Start Date: 2005-04-20 | |||||||||||
| Sponsor Name: Institut de Recherches Internationales | |||||||||||||
| Full Title: Effects of ivabradine on cardiovascular events in patients with stable coronary artery disease and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled int... | |||||||||||||
| Medical condition: Coronary artery disease | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: HU (Completed) LT (Completed) FI (Completed) LV (Completed) IT (Completed) CZ (Completed) SK (Completed) GB (Completed) DK (Completed) AT (Completed) SE (Completed) EE (Completed) DE (Completed) IE (Completed) ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-002342-35 | Sponsor Protocol Number: SKY0402-C-201 | Start Date: 2005-04-20 | |||||||||||
| Sponsor Name: SkyePharma, Inc. | |||||||||||||
| Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Dose-Escalating/De-Escalating Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of a Single Dose of Sustained-Release Encapsulated Bupiv... | |||||||||||||
| Medical condition: Pain following inguinal hernia repair | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-004654-19 | Sponsor Protocol Number: 1526-IMIQ | Start Date: 2005-04-20 | |||||||||||
| Sponsor Name: 3M ITALIA | |||||||||||||
| Full Title: Multicenter, randomized, double-blind, vehicle-controlled study comparing recurrence rate following imiquimod 5% cream or vehicle 3 times per week for 4 weeks prior to ablative therapy in subjects ... | |||||||||||||
| Medical condition: External ano-genital warts | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-004139-74 | Sponsor Protocol Number: PB1 | Start Date: 2005-04-20 | ||||||
| Sponsor Name: Neurologisk afdeling F | ||||||||
| Full Title: Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect. (Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) | ||||||||
| Medical condition: Parkinson's Disease | ||||||||
|
||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||
| Trial protocol: DK (Ongoing) | ||||||||
| Trial results: (No results available) | ||||||||
| EudraCT Number: 2005-000005-65 | Sponsor Protocol Number: BICOMBO | Start Date: 2005-04-20 | |||||||||||
| Sponsor Name: Servicio de Infecciones. Hospital Clínic de Barcelona | |||||||||||||
| Full Title: Comparación de dos alternativas de combinación de nucleósidos, en pacientes infectados por el HIV-1 con supresión virológica mantenida y en tratamiento con lamivudina (3TC). Estudio aleatorizado, m... | |||||||||||||
| Medical condition: Chronic HIV infection | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2005-000093-50 | Sponsor Protocol Number: 0431-035 | Start Date: 2005-04-20 | |||||||||||
| Sponsor Name: Merck Sharp & Dohme (Sweden) AB | |||||||||||||
| Full Title: A Multicenter, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemi... | |||||||||||||
| Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: SE (Completed) IS (Completed) AT (Completed) DK (Completed) CZ (Completed) ES (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||